Skip to main content

Table 1 Descriptive analyses final cohort (N = 86)

From: Diagnostic performance of salivary urea nitrogen dipstick to detect and monitor acute kidney disease in patients with malaria

Variable

Value

Age (years)

21.5 ± 9.5

Male (N; %)

61 (71%)

Presence of kidney disease (N; %)

27 (32%)

BUN at day 1 (mg/dL)

39.5 ± 14.9

sCr at day 1 (mg/dL)

5.38 ± 5.42

KDIGO—AKI stage 1 (N; %)

8 (29.7%)

KDIGO—AKI stage 2 (N; %)

4 (14.8%)

KDIGO—AKI stage 3 (N; %)

3 (11.1%)

AKD no AKI (N; %)

12 (44.4%)

  1. KDIGO classification: (a) AKI stage 1: variation of 1.5–1.9 times baseline serum creatinine OR ≥ 0.3 mg/dL (≥ 26.5 mmol/L) increase; (b) AKI stage 2: variation of 2.0–2.9 times baseline serum creatinine; (c) AKI stage 3: variation of 3.0 times baseline serum creatinine OR increase in serum creatinine to ≥ 4.0 mg/dL (≥ 353.6 mmol/L) OR initiation of renal replacement therapy OR, in patients < 18 years, decrease in eGFR to < 35 mL/min per 1.73 m2
  2. BUN blood urea nitrogen, sCR serum creatinine